tunart / iStockphoto.com

21 November 2017Big Pharma

London loses EMA to Amsterdam

The European Medicines Agency (EMA) will relocate from its London, UK headquarters to Amsterdam, in the Netherlands.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Emer Cooke becomes first woman to lead EMA

18 November 2020 The first woman to act as executive director of the European Medicines Agency (EMA) has officially started in the role.

EMA settles Brexit dispute; issues drug shortages guidance

8 July 2019 The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.

EMA scales back activities ahead of Brexit

2 August 2018 The European Medicines Agency has announced plans to temporarily further scale back and suspend activities in order to cope with a more significant staff loss from the agency’s relocation than was originally expected.

More on this story

Emer Cooke becomes first woman to lead EMA

18 November 2020 The first woman to act as executive director of the European Medicines Agency (EMA) has officially started in the role.

EMA settles Brexit dispute; issues drug shortages guidance

8 July 2019 The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.

EMA scales back activities ahead of Brexit

2 August 2018 The European Medicines Agency has announced plans to temporarily further scale back and suspend activities in order to cope with a more significant staff loss from the agency’s relocation than was originally expected.

More on this story

Emer Cooke becomes first woman to lead EMA

18 November 2020 The first woman to act as executive director of the European Medicines Agency (EMA) has officially started in the role.

EMA settles Brexit dispute; issues drug shortages guidance

8 July 2019 The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.

EMA scales back activities ahead of Brexit

2 August 2018 The European Medicines Agency has announced plans to temporarily further scale back and suspend activities in order to cope with a more significant staff loss from the agency’s relocation than was originally expected.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB